Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ALPA Stock Summary
In the News
ALPA Financial details
Company Rating
Neutral
Market Cap
193.74M
Income
-9.86M
Revenue
3.73M
Book val./share
1.12
Cash/share
0.43
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
32.39
Forward P/E
-
PEG
0.38
P/S
-
P/B
0.27
P/C
-
P/FCF
-380.92
Quick Ratio
0.01
Current Ratio
0.05
Debt / Equity
0.04
LT Debt / Equity
0.04
-
-
EPS (TTM)
-0.29
EPS next Y
-
EPS next Q
-
EPS this Y
-134.67%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-576.92%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
291.46%
Inst Trans
0.97%
ROA
1%
ROE
1%
ROC
-0.01%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
19.77M
Shs Float
11.45M
-
-
-
-
Target Price
-
52W Range
8.73-11.83
52W High
-
52W Low
-
RSI
-
Rel Volume
0.46
Avg Volume
184.85K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
ALPA Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2021-12-31 | 2022-12-31 |
---|---|---|---|
2.02K | 2.02K | ||
Revenue per share | 0 | 0 | |
Net income per share | -0.03 | 0.01 | |
Operating cash flow per share | -0.04 | -0.02 | |
Free cash flow per share | -0.04 | -0.02 | |
Cash per share | 14.14 | 0.01 | |
Book value per share | 13.63 | 7.58 | |
Tangible book value per share | 13.63 | 7.58 | |
Share holders equity per share | 13.63 | 7.58 | |
Interest debt per share | 0 | -0.11 | |
Market cap | 105.63M | 196.06M | |
Enterprise value | 104.86M | 195.87M | |
P/E ratio | -320.69 | 956.38 | |
Price to sales ratio | 0 | 0 | |
POCF ratio | -234.13 | -401.14 | |
PFCF ratio | -234.13 | -401.14 | |
P/B Ratio | 0.71 | 1.31 | |
PTB ratio | 0.71 | 1.31 | |
EV to sales | 0 | 0 | |
Enterprise value over EBITDA | -173.18 | -50.23 | |
EV to operating cash flow | -232.41 | -400.76 | |
EV to free cash flow | -232.41 | -400.76 | |
Earnings yield | 0 | 0 | |
Free cash flow yield | 0 | 0 | |
Debt to equity | 0 | 0 | |
Debt to assets | 0 | 0 | |
Net debt to EBITDA | 1.28 | 0.05 | |
Current ratio | 2.95 | 0.17 | |
Interest coverage | 0 | 0.73 | |
Income quality | 1.37 | -2.38 | |
Dividend Yield | 0 | 0 | |
Payout ratio | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | |
Research and developement to revenue | 0 | 0 | |
Intangibles to total assets | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | |
Capex to revenue | 0 | 0 | |
Capex to depreciation | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | |
Graham number | 3.03 | 1.33 | |
ROIC | 0 | 0 | |
Return on tangible assets | 0 | 0 | |
Graham Net | 13.61 | -0.35 | |
Working capital | 643.17K | -1.4M | |
Tangible asset value | 149.69M | 149.89M | |
Net current asset value | -4.76M | -6.8M | |
Invested capital | 0 | 0 | |
Average receivables | 0 | 0 | |
Average payables | 0 | 629.17K | |
Average inventory | 0 | 0 | |
Days sales outstanding | 0 | 0 | |
Days payables outstanding | 0 | 0 | |
Days of inventory on hand | 0 | 0 | |
Receivables turnover | 0 | 0 | |
Payables turnover | 0 | 0 | |
Inventory turnover | 0 | 0 | |
ROE | 0 | 0 | |
Capex per share | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q3
Metric | History | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-09-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0.2 | |
Net income per share | -0.02 | 0.04 | 0.01 | 0.03 | -0.62 | |
Operating cash flow per share | 0 | -0.01 | -0.01 | -0.01 | -0.32 | |
Free cash flow per share | 0 | -0.01 | -0.01 | -0.01 | -0.32 | |
Cash per share | 0.03 | 0.02 | 0.01 | 0 | 0.43 | |
Book value per share | 7.53 | 7.57 | 7.58 | 7.88 | 1.12 | |
Tangible book value per share | 7.53 | 7.57 | 7.58 | 7.88 | -1.14 | |
Share holders equity per share | 7.53 | 7.57 | 7.58 | 7.88 | 1.12 | |
Interest debt per share | -0.01 | -0.06 | -0.05 | -0.08 | 0.04 | |
Market cap | 191.36M | 192.55M | 196.06M | 200.66M | 182.57M | |
Enterprise value | 190.81M | 192.17M | 195.87M | 200.64M | 175.48M | |
P/E ratio | -137.88 | 57.25 | 205.34 | 87.08 | -3.96 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 48.96 | |
POCF ratio | -4.43K | -1.84K | -1.04K | -1.17K | -30.96 | |
PFCF ratio | -4.43K | -1.84K | -1.04K | -1.17K | -30.96 | |
P/B Ratio | 1.29 | 1.29 | 1.31 | 1.29 | 8.73 | |
PTB ratio | 1.29 | 1.29 | 1.31 | 1.29 | 8.73 | |
EV to sales | 0 | 0 | 0 | 0 | 47.06 | |
Enterprise value over EBITDA | -388.48 | -233.74 | -95.87 | -82.49 | -15.81 | |
EV to operating cash flow | -4.41K | -1.84K | -1.04K | -1.17K | -29.75 | |
EV to free cash flow | -4.41K | -1.84K | -1.04K | -1.17K | -29.75 | |
Earnings yield | 0 | 0 | 0 | 0 | -0.06 | |
Free cash flow yield | 0 | 0 | 0 | 0 | -0.03 | |
Debt to equity | 0 | 0 | 0 | 0 | 0.04 | |
Debt to assets | 0 | 0 | 0 | 0 | 0.01 | |
Net debt to EBITDA | 1.12 | 0.46 | 0.09 | 0.01 | 0.64 | |
Current ratio | 0.58 | 0.64 | 0.17 | 0.05 | 1.03 | |
Interest coverage | 1.39 | 0.1 | 0.7 | 0.45 | 78.28 | |
Income quality | 0.12 | -0.12 | -0.79 | -0.3 | 0.93 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0.38 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0.45 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0.51 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.72 | 2.69 | 1.44 | 2.27 | 3.95 | |
ROIC | -0.01 | 0 | 0 | 0 | -0.23 | |
Return on tangible assets | 0 | 0.01 | 0 | 0 | -0.29 | |
Graham Net | -0.3 | -0.3 | -0.35 | -0.13 | -2.02 | |
Working capital | -444.26K | -301.72K | -1.4M | -2.5M | 1.16M | |
Tangible asset value | 148.81M | 149.65M | 149.89M | 155.87M | -21.28M | |
Net current asset value | -5.85M | -5.71M | -6.8M | -2.5M | -22.44M | |
Invested capital | 0 | 0 | 0 | 0 | 0.04 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 629.17K | 1.54M | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 347.68 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 1.04K | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 571.79 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0.26 | |
Payables turnover | 0 | 0 | 0 | 0 | 0.09 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0.16 | |
ROE | 0 | 0.01 | 0 | 0 | -0.55 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ALPA Frequently Asked Questions
What is Alpha Healthcare Acquisition Corp. III stock symbol ?
Alpha Healthcare Acquisition Corp. III is a US stock , located in New york of Ny and trading under the symbol ALPA
What is Alpha Healthcare Acquisition Corp. III stock quote today ?
Alpha Healthcare Acquisition Corp. III stock price is $- today.
Is Alpha Healthcare Acquisition Corp. III stock public?
Yes, Alpha Healthcare Acquisition Corp. III is a publicly traded company.